Jaeseung Kim
0009-0009-0387-8525
Publication & Citation Trends
Most Cited Works
Publications
73 total
Abstract 2255: Patient pharmacodynamic biomarker and pk evaluation results from an ongoing phase I dose-escalation study of q702, an axl, mer and csf1r kinase inhibitor in patients with advanced solid tumors
Cited by 1
Semantic Scholar
Sirtuin 6 is required for the integrated stress response and resistance to inhibition of transcriptional cyclin-dependent kinases OA
Cited by 12
Semantic Scholar
Abstract 5977: Evaluation of the potential combination regimens for q901, a clinical stage selective cdk7 inhibitor, as a DNA damage repair inhibitor
Cited by 0
Semantic Scholar
Abstract B075: Sirtuin 6 histone deacetylase is required for the integrated stress response and resistance to inhibition of transcriptional cyclin dependent kinases in Pancreatic Ductal Adenocarcinoma
Cited by 0
Semantic Scholar
Abstract 2574: Q901; a highly selective covalent cdk7 inhibitor inducing substantial anti-tumor effect in a broad spectrum of solid tumor lineages
Cited by 2
Semantic Scholar
Abstract 416: A novel non-covalent and rapidly reversible proteasome inhibitor for multiple myeloma and various solid cancers
Cited by 0
Semantic Scholar
A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment OA
Cited by 17
Semantic Scholar
Research Topics
Cancer therapeutics and mechanisms
(10)
Tuberculosis Research and Epidemiology
(9)
DNA and Nucleic Acid Chemistry
(9)
Cancer Genomics and Diagnostics
(7)
Phagocytosis and Immune Regulation
(7)
Frequent Co-Authors
Affiliations
Ontario Institute for Cancer Research
University of Southern California
Brigham and Women's Hospital
University Health Network
State University of New York